Literature DB >> 23773746

[Kaposi's disease: an unusual side-effect of topical corticosteroids].

H Boudhir1, M Mael-Ainin, K Senouci, B Hassam, L Benzekri.   

Abstract

BACKGROUND: Kaposi's sarcoma is an angiogenic tumour associated with HHV8 infection. There are several clinical forms, including those related to acquired immunosuppression. We report a case of nodular lesions in Kaposi's disease that appeared during treatment of bullous pemphigoid with topical corticosteroids. PATIENTS AND METHODS: A 74-year-old female patient presented bullous pemphigoid lesions on all four limbs that were treated with clobetasol cream, a topical corticosteroid. After 2 months of treatment, the patient noted the appearance of several asymptomatic purple, erythematous, papulonodular lesions of elastic consistency on her right thigh and both legs. The histological examination revealed Kaposi's disease with positive immunolabelling for HHV8 in the tumour cells. HIV serology was negative. The lesions disappeared 4 months after cessation of corticosteroid therapy and the patient was still in remission one year later. COMMENT: Authentic "Mediterranean" cutaneous Kaposi's disease was apparently revealed in this patient during treatment with extremely potent topical corticosteroids, before regressing completely on discontinuation of the medication. We discuss the various mechanisms that could have contributed to this side-effect of dermal corticosteroids, whose sustained application over a wide area caused HHV8 antigen reactivation.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23773746     DOI: 10.1016/j.annder.2013.04.078

Source DB:  PubMed          Journal:  Ann Dermatol Venereol        ISSN: 0151-9638            Impact factor:   0.777


  5 in total

1.  Impetiginized Dyshidrotic Eczema.

Authors:  Georgi Tchernev; Matteo Zanardelli; Cristiana Voicu; Ilko Bakardzhiev; Torello Lotti; Jacopo Lotti; Katlein França; Atanas Batashki; Uwe Wollina
Journal:  Open Access Maced J Med Sci       Date:  2017-07-19

2.  Steroids are a risk factor for Kaposi's sarcoma-immune reconstitution inflammatory syndrome and mortality in HIV infection.

Authors:  Mónica Fernández-Sánchez; María C Iglesias; Yuria Ablanedo-Terrazas; Christopher E Ormsby; Claudia Alvarado-de la Barrera; Gustavo Reyes-Terán
Journal:  AIDS       Date:  2016-03-27       Impact factor: 4.177

3.  The Spectrum of Underlying Causes of Iatrogenic Kaposi's Sarcoma in a Large Series: A Retrospective Study.

Authors:  Can Baykal; Tugba Atci; Nesimi Buyukbabani; Armagan Kutlay
Journal:  Indian J Dermatol       Date:  2019 Sep-Oct       Impact factor: 1.494

Review 4.  [What's new in clinical dermatology?].

Authors:  M Janier
Journal:  Ann Dermatol Venereol       Date:  2013-11       Impact factor: 0.777

5.  [Kaposi's sarcoma in a steroid-treated temporal arteritis].

Authors:  Paula Martínez García; Irene Maderuelo Riesco; Carlos Tarrazo Tarrazo
Journal:  Aten Primaria       Date:  2018-10-30       Impact factor: 1.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.